Month: August 2021

Q2 Revenue Increases 12%, Gross Margin Increases 77% SAN FRANCISCO, CA, Aug. 12, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announced financial results for the second quarter of 2021, ended June 30, 2021. Second Quarter 2021 Financial HighlightsTotal revenue in the second quarter was $4,476,000, an increase of 12.2% from the comparable period in 2020. Proton therapy revenue of $1,549,000 increased 10.6% from the second quarter of 2020 due to higher average reimbursement per fraction. Gamma Knife revenue of $2,927,000 increased 13.0% compared to the second quarter of 2020 due to higher volumes and...

SANTA MONICA, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) — Super League Gaming (Nasdaq: SLGG), a global leader in video gaming and esports experiences and entertainment for players of all ages, announced today the formation of its Young Gamer Network and Core Gamer Network to continue driving elevated levels of audience engagement and awareness for the company’s roster of high-profile advertisers, sponsors, and partners. In addition, the company announced the acquisition of Bannerfy, an intelligent technology platform that enables digital video and live streaming creators to collaborate with tier one sponsors on their social media channels including YouTube through scalable and custom premium placements. Recent brand partners focused on reaching young gamers through Super League programs include Moose Toys, ASTRO Gaming, Logitech...

MURRAY, Utah, Aug. 12, 2021 (GLOBE NEWSWIRE) — R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced the appointment of Agnes Bundy Scanlan, president of The Cambridge Group LLC, to the company’s board of directors, effective August 11, 2021. Ms. Bundy Scanlan has more than 30 years of experience across regulatory risk management, compliance, and consumer financial protection. She has served as president of The Cambridge Group LLC, a regulatory risk management advisory firm, since May 2020. Prior to this role, Ms. Bundy Scanlan served as senior advisor at Treliant LLC from 2017 to 2020 and from 2012 to 2015, prior to which she was the northeast regional director at the Consumer Financial Protection Bureau...

SAN CARLOS, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the second quarter of 2021 and filed its quarterly report on Form 10-Q for the three and six months ended June 30, 2021 with the Securities and Exchange Commission. Q2 and Recent Business Highlights:CardiAMP® Autologous Cell Therapy for ischemic heart failure (BCDA-01)The independent Data Safety Monitoring Board (DSMB) completed its fourth prespecified data review for the Phase III pivotal CardiAMP Heart Failure Trial on June 22, 2021. The DSMB preformed a risk-benefit assessment, which typically includes an analysis of futility to reach the primary endpoint of the clinical trial as designed....

SHANGHAI, China, Aug. 12, 2021 (GLOBE NEWSWIRE) — China Agricultural University will join Pinduoduo (NASDAQ: PDD) as a co-organizer of the Smart Agriculture Competition, a unique contest that aims to foster interdisciplinary innovation by marrying algorithms and agronomy. The Smart Agriculture Competition, which is being held for a second year, aims to promote the development of cost-effective technology that can help farmers to increase their productivity and improve their livelihoods in an environmentally sustainable manner. This year, the contest will draw teams from around the world to cultivate tomatoes using a combination of agronomic knowledge, algorithmic modeling, and precision automation. “The Smart Agriculture Competition plays a unique role in that it aims to foster innovation that is usable by smallholder farmers,...

Company announces acceptance of seven abstracts with data from multiple clinical trials evaluating setmelanotide for rare genetic diseases of obesity BOSTON, Aug. 12, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, today announced that it will present data from multiple clinical trials at the 59th Annual European Society for Paediatric Endocrinology (ESPE) Meeting to be held virtually September 22-26, 2021. In total, Rhythm and its clinical collaborators will present seven abstracts. This includes three oral presentations detailing results from a pivotal Phase 3 clinical trial evaluating setmelanotide in Bardet-Biedl Syndrome and results from the Company’s Phase 2 basket trial...

First point-of-need, PCR system capable of using conventional probe-based chemistry or inexpensive, rapidly available SYBR Green chemistry BEVERLY, Mass., Aug. 12, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) a molecular diagnostics company developing automated rapid polymerase chain reaction (PCR) testing solutions for veterinary diagnostics and biopharmaceutical manufacturing, is pleased to announce that its MiQLab™ System is the first point-of-need system that can be configured to perform PCR using either probe-based chemistry or SYBR Green chemistry coupled with melt curve analysis. Dr. Nathan Walsh, VP of Applications and Informatics stated, “Traditional real time PCR uses expensive hydrolysis probes that have long lead times for manufacturing, whereas SYBR Green-based PCR uses inexpensive primers...

– Global immuno-oncology experts bring decades of experience to advance company’s transformative research and development pipeline – SAN FRANCISCO, Calif. and SUZHOU, China, Aug. 12, 2021 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene” or the “Company”) (Nasdaq: ADAG), a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based immunotherapies, today announced appointment of an interim Chief Medical Officer and new members of its Scientific and Strategic Advisory Board (the “SAB”). The appointments include pioneers in the immuno-oncology field: Steven Fischkoff, M.D., Stanley Frankel, M.D., FACP and Robert Spiegel, M.D., FACP. “We are honored to have such a prestigious group with deep therapeutics development experience to join our efforts in...

SANTA MONICA, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) — GoodRx Holdings, Inc. (Nasdaq: GDRX), America’s leading resource for healthcare savings, has released its second quarter 2021 financial results and posted a letter to shareholders on the Overview page of its investor relations website at https://investors.goodrx.com. GoodRx management will host a conference call and webcast today at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook. Today’s conference call and webcast will be extended to feature a presentation on pharma manufacturer solutions. Second Quarter 2021 Results Conference Call  Date: Thursday, August 12, 2021  Time: 5:00 a.m. Pacific Time / 8:00 a.m. Eastern Time  Webcast: https://investors.goodrx.com (live and replay)  Dial-in number: (833) 614-1447Approximately...